{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"}],"units":"Participants"}],"description":"Measured as: the number of eligible patients approached and number who elect to enter the study and participate in the novel care model rather than through the traditional hospice care model.","groups":[{"description":"Patients with aggressive hematologic malignancies who are hospice eligible, not pursuing further cancer directed therapy, and whose primary hematologist is planning to initiate a conversation regarding transition to hospice will be eligible for enrollment.\n\nTransfusion support: Patients will be offered symptom-driven transfusion support in addition to standard hospice care","id":"OG000","title":"Intervention Arm"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Eligible patients approached for participation","reportingStatus":"POSTED","timeFrame":"Through study completion, on average 2 years","title":"Proportion of Eligible Patients Choosing to Participate in the Care Model Under Study Rather Than Standard of Care.","type":"PRIMARY","unitOfMeasure":"Participants"}